Seminars in Perinatology
Volume 34, Issue 2 , Pages 105-120 , April 2010

Newborn Screening System Performance Evaluation Assessment Scheme (PEAS)

  • Bradford L. Therrell Jr, MS, PhD

      Affiliations

    • National Newborn Screening and Genetics Center, Austin, TX
    • University of Texas Health Center at San Antonio, San Antonio, TX
    • Corresponding Author InformationAddress reprint requests to Bradford L. Therrell Jr, MS, PhD, National newborn Screening and Genetics Resource Center, 1912 W. Anderson Lane, Austin, TX 78759
    • ,
  • Marion Schwartz, MSN, RN

      Affiliations

    • National Newborn Screening and Genetics Center, Austin, TX
    • University of Texas Health Center at San Antonio, San Antonio, TX
    • ,
  • Carol Southard, BS

      Affiliations

    • National Newborn Screening and Genetics Center, Austin, TX
    • University of Texas Health Center at San Antonio, San Antonio, TX
    • ,
  • Donna Williams, BS

      Affiliations

    • National Newborn Screening and Genetics Center, Austin, TX
    • University of Texas Health Center at San Antonio, San Antonio, TX
    • ,
  • W. Harry Hannon, PhD

      Affiliations

    • Newborn Screening Branch, Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • Marie Y. Mann, MD, MPH

      Affiliations

    • Maternal and Child Health Bureau, Health Resources and Services Administration, Rockville, MD
    • ,
  • PEAS Organizing and Working Groups

References 

  1. Therrell BL. US newborn screening policy dilemmas for the twenty-first century. Mol Genet Metab. 2001;74:64–74
  2. Pass KA, Lane PA, Fernhoff PM, et al. US newborn screening system guidelines II: follow-up of children, diagnosis, management, and evaluation (Statement of the Council of Regional Networks for Genetic Services (CORN)). J Pediatr. 2000;137:S1–S46
  3. Clinical and Laboratory Standards Institute (CLSI). Newborn Screening Follow-up; Approved Guideline: CLSI Document I/LA27-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2006;
  4. Kemper AR, Boyle CA, Aceves J, et al. Long-term follow-up after diagnosis resulting from newborn screening: statement of the US Secretary of Health And Human Services' Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Genet Med. 2008;10:259–261
  5. Public Law: 100-578: Clinical Laboratory Improvement Amendments of 1988
  6. Slazyk WE, Hannon WH. Quality assurance in the newborn screening laboratory. In:  Therrell BL editors. Laboratory Methods for Neonatal Screening. Washington, DC: American Public Health Association; 1993;p. 23–46
  7. US Department of Health and Human Services. Healthy People 2010: Understanding and Improving Health. (ed 2). Washington, DC: US Government Printing Office; 2000;
  8. Puryear M, Weissman G, Watson M, et al. The regional genetic and newborn screening service collaboratives: the first two years. Ment Retard Dev Disabil Res Rev. 2006;12:288–292
  9. Therrell BL, Hannon WH. National evaluation of US newborn screening system components. Ment Retard Dev Disabil Res Rev. 2006;12:236–245
  10. Clinical and Laboratory Standards Institute (CLSI). Newborn Screening for Preterm, Low Birth Weight, and Sick Newborns; Approved Guideline: CLSI Document I/LA31-A. Wayne, PA: Clinical and Laboratory Standards Institute; 2009;
  11. Kaye CI. Committee on Genetics: introduction to the newborn screening fact sheets. Pediatrics. 2006;118:1304–1312
  12. Howell RR, Lloyd-Puryear M: From developing guidelines to implementing legislation: actions of the US Advisory Committee on Heritable Disorders in Newborns and Children towards advancing and improving newborn screening. Semin Perinatol, in press
  13. American Academy of Pediatrics, Newborn Screening Task Force. serving the family from birth to medical home—a blueprint for the future. Pediatrics. 2000;106(suppl):383–427
  14. Fant KE, Clark SJ, Kemper AR. Completeness and complexity of information available to parents from newborn screening programs. Pediatrics. 2005;115:1268–1272
  15. Hinman AR, Atkinson D, Diehn TN, et al. Principles and core functions of integrated child health information systems. J Public Health Manag Pract. 2004;11(suppl):52–56
  16. Therrell BL. Data integration and warehousing: coordination between newborn screening and related health programs. Southeast Asian J Trop Med Public Health. 2003;34(suppl 3):63–68
  17. Hinman AR, Mann MY, Singh RH. Newborn dried bloodspot screening: mapping the clinical and public health components and activities. Genet Med. 2009;11:418–424
  18. Downing GJ, Zuckerman AE, Coon C, et al: Enhancing the quality and efficiency of newborn screening programs through the use of health information technology. Semin Perinatol (in press)
  19. Therrell BL, Panny SR, Davidson A, et al. US newborn screening system guidelines: statement of the Council of Regional Networks for Genetic Services. Screening. 1992;1:135–147
  20. Johnson K, Lloyd-Puryear MA, Mann MY, et al. Financing state newborn screening programs: sources and uses of funds. Pediatrics. 2006;117:270–279
  21. Therrell BL, Williams D, Johnson K, et al. Financing newborn screening: sources, issues, and future considerations. J Public Health Manag Pract. 2007;13:207–213
  22. Pass KA, Thoene J, Watson MS. Emergency preparedness for newborn screening and genetic services. Genet Med. 2009;11:455–464
  23. Hasegawa LE, Au SM, Matsumoto CA. The obstetrician's role in newborn metabolic screening: a physician survey. Hawaii Med J. 2005;64(253):239–243
  24. Davis TC, Humiston SG, Arnold CL, et al. Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Pediatrics. 2006;117:326–340
  25. Larsson A, Therrell BL. Newborn screening: the role of the obstetrician. Clin Obstet Gynecol. 2002;45:697–710
  26. Clinical and Laboratory Standards Institute (CLSI). Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard. CLSI Document LA4-A5 (ed 5). Wayne, PA: Clinical and Laboratory Standards Institute; 2007;
  27. Forsberg SA. Infant metabolic screening: a total quality management approach. J Obstet Gynecol Neonatal Nurs. 1997;26:257–261
  28. American Academy of Pediatrics, Committee on Genetics. Issues in newborn screening. Pediatrics. 1992;89:345–349
  29. Clinical and Laboratory Standards Institute (CLSI). Clinical Laboratory Safety, Approved Guideline. CLSI document GP17-A2 (ed 2). Wayne, PA: Clinical and Laboratory Standards Institute; 2004;
  30. Clinical and Laboratory Standards Institute (CLSI). Protection of Laboratory Workers from Occupationally Acquired Infections; Approved Guideline. CLSI document M29-A3 (ed 3). Wayne, PA: Clinical and Laboratory Standards Institute; 2005;
  31. David-Padilla C, Basilio J, Therrell BL. A performance evaluation and assessment scheme (PEAS) for improving the Philippine newborn screening program. Acta Med Philipp. 2009;43(genet issue 3):58–63
  32. American College of Medical Genetics, Newborn Screening Expert Group. Newborn screening: toward a uniform screening panel and system. Genet Med. 2006;8(suppl 1):1–252

 Supported in part by HRSA grants U32MC00148 and U36MC02604.

PII: S0146-0005(09)00107-4

doi: 10.1053/j.semperi.2009.12.002

Seminars in Perinatology
Volume 34, Issue 2 , Pages 105-120 , April 2010

Article Tools